While there are many factors why patients with acute myeloid leukemia are ineligible for allogeneic stem cell transplant, such as age, financial hurdles, or other comorbidities, these factors are often compounded by social determinants of health, which can act as a significant barrier to consolidation therapy and long-term remission for these patients. In this episode, CANCER BUZZ speaks with Keri Maher, DO, Director of the Acute Leukemia Program, and assistant professor at Virginia Commonwealth University’s Massey Cancer Center about strategies to address these disparities and optimize care and treatment options for patients with acute myeloid leukemia who do not receive a transplant.
“We know that patients who are ineligible for transplant may be so because of social determinants in and of themselves…[It is important to understand that] there are three categories of barriers that patients face when accessing care. I like to think of them as patient-based barriers, institutional-based barriers, and social-based barriers.” – Keri Maher, DO
Guest:
Keri R. Maher, DO MS
Assistant Professor of Medicine
Director, Acute Leukemia Program
Massey Cancer Center
Virginia Commonwealth University
Richmond, VA
This is the first episode of a four-part series developed in connection with the ACCC education program Achieving and Maintaining Better Outcomes for Patients with Acute Myeloid Leukemia and was made possible with support by Bristol Myers-Squibb.
Additional Reading/Sources
· Healthcare Disparities Among African Americans Are Pervasive in the Treatment of AML. Blood. (2022)
· Minority Health Disparities in Acute Myeloid Leukemia: A Metropolitan, Single-Center Retrospective Analysis. Blood. (2021)
· The American Association for Cancer Research - Cancer Disparities Progress Report
· Structural racism is a mediator of disparities in acute myeloid leukemia outcomes. Blood. (2022)
· Disparities in mortality among acute myeloid leukemia-related hospitalizations. Cancer Med. (2023)
Social Determinants of Health in Metastatic Breast Cancer
Overcoming Barriers to Holistic Survivorship Care for Immunotherapy Patients
Integrating Genetic Counselors in Routine Genitourinary Care
A Multidisciplinary Approach to Anemia Management in High-Risk MDS and AML
Improving Care Delivery to Patients Newly Diagnosed with Breast Cancer
Highlights from the ACCC Working Summit: Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education
Care Action Plans for People with Cancer
Beyond the Brush: Navigating Dental Care in Head & Neck Cancer
Navigating the Operational Challenges of Treatment with Bispecific Antibodies
Policy Perspectives on Biomarker Testing Coverage for 2024
Open Enrollment: Best Practices for End-of-Year Prep
Disparities in Accessing Care for AML Patients: Challenges and Solutions
Clarifying the Role of Maintenance Therapy
A Conversation With ACCC’s Outgoing and Incoming Presidents at the ACCC 50th Annual Meeting and Cancer Center Business Summit
LIVE from AMCCBS: White House Update
LIVE from AMCCBS: Capitol Hill Update
LIVE from AMCCBS: Institute for Comprehensive Cancer Care Services
LIVE from AMCCBS: New Payments for Patient Navigation
LIVE from AMCCBS: Financial Advocacy Resources
Making the Case for Head & Neck Cancer Patient Care Navigators
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain